Blank Rome partners Rachael G. Pontikes and Emily L. Hussey will serve as speakers at the American Society for Pharmacy Law’s Developments in Pharmacy Law XXXVII, being held November 5 through 7, 2026, in Austin, Texas. Blank Rome is pleased to be a Silver Sponsor of the conference.
Rachael and Emily’s session, “The Compounded Tirzepatide and Semaglutide Saga—the Litigation, the Proposed Legislation, and the Regulatory Challenges,” will take place on Friday, November 6, from 3:55 to 4:55 p.m.
About the Session
Drug shortages and of GLP-1s have put compounding into the national spotlight—creating litigation, proposed legislation, and regulatory challenges presenting novel issues for the courts, legislatures, and regulators. The prescribing, making, and marketing of these compounded drugs is under intense scrutiny by drug manufacturers, legislators, and federal and state regulators. This advanced-level presentation explores the court actions by Eli Lilly and Novo Nordisk, the proposed state legislation targeted at the active pharmaceutical ingredient for GLP-1s, and the novel regulatory issues the popularity of these drugs presents.
For more information and to register, please visit the event webpage.